Skip navigation

Reputation Management Tactics to Establish Credibility for Products and Services

October 2-3, 2019
  • Cambridge, MA

The pharmaceutical industry’s reputation and corporate responsibility is proving to be a fundamental business challenge to navigate. CBI’s Bio/Pharm Corporate Communications Forum highlights effective strategies to build credibility and trust to ultimately enhance brand image.

Don’t miss this opportunity to contribute to the conversation, face-to-face with industry experts to address the value that a medicine brings and develop positive perceptions of your organization and brands. This event demonstrates how to better understand the bio/pharmaceutical industry’s efforts to increase transparency and create meaningful connections with consumers.

  • Insight into how companies are tackling their reputation management and crisis management
  • Assess the gaps in regulatory policy and its impact on pharmaceutical reputation
  • Analyze effective digital and social media strategies to best reach the patient
  • Understand the value of public engagement and reputation management (increased spend on government affairs, patient advocacy, PR)
  • Address drug price transparency and determine effective strategies to communicate with patients and physicians patient

Bio/Pharm Corporate Communications Forum

Reputation Management Tactics to Establish Credibility for Products and Services

The pharmaceutical industry’s reputation and corporate responsibility is proving to be a fundamental business challenge to navigate. CBI’s Bio/Pharm Corporate Communications Forum highlights effective strategies to build credibility and trust to ultimately enhance brand image.

Don’t miss this opportunity to contribute to the conversation, face-to-face with industry experts to address the value that a medicine brings and develop positive perceptions of your organization and brands. This event demonstrates how to better understand the bio/pharmaceutical industry’s efforts to increase transparency and create meaningful connections with consumers.

  • Insight into how companies are tackling their reputation management and crisis management
  • Assess the gaps in regulatory policy and its impact on pharmaceutical reputation
  • Analyze effective digital and social media strategies to best reach the patient
  • Understand the value of public engagement and reputation management (increased spend on government affairs, patient advocacy, PR)
  • Address drug price transparency and determine effective strategies to communicate with patients and physicians patient